- Home
- ZDAI vs INTS Comparison
ZDAI vs INTS Comparison
Compare ZDAI & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDAI
- INTS
- Stock Information
- Founded
- ZDAI 2022
- INTS 2012
- Country
- ZDAI Hong Kong
- INTS United States
- Employees
- ZDAI N/A
- INTS N/A
- Industry
- ZDAI General Bldg Contractors - Nonresidential Bldgs
- INTS Biotechnology: Pharmaceutical Preparations
- Sector
- ZDAI Consumer Discretionary
- INTS Health Care
- Exchange
- ZDAI Nasdaq
- INTS Nasdaq
- Market Cap
- ZDAI 14.8M
- INTS 12.2M
- IPO Year
- ZDAI 2024
- INTS 2023
- Fundamental
- Price
- ZDAI $0.49
- INTS $0.25
- Analyst Decision
- ZDAI
- INTS Strong Buy
- Analyst Count
- ZDAI 0
- INTS 4
- Target Price
- ZDAI N/A
- INTS $4.50
- AVG Volume (30 Days)
- ZDAI 92.7K
- INTS 5.8M
- Earning Date
- ZDAI 11-11-2025
- INTS 11-12-2025
- Dividend Yield
- ZDAI N/A
- INTS N/A
- EPS Growth
- ZDAI N/A
- INTS N/A
- EPS
- ZDAI N/A
- INTS N/A
- Revenue
- ZDAI $19,275,673.00
- INTS N/A
- Revenue This Year
- ZDAI N/A
- INTS N/A
- Revenue Next Year
- ZDAI N/A
- INTS N/A
- P/E Ratio
- ZDAI N/A
- INTS N/A
- Revenue Growth
- ZDAI 43.16
- INTS N/A
- 52 Week Low
- ZDAI $0.37
- INTS $0.19
- 52 Week High
- ZDAI $107.36
- INTS $3.40
- Technical
- Relative Strength Index (RSI)
- ZDAI 37.51
- INTS 45.63
- Support Level
- ZDAI $0.48
- INTS $0.23
- Resistance Level
- ZDAI $0.53
- INTS $0.26
- Average True Range (ATR)
- ZDAI 0.04
- INTS 0.03
- MACD
- ZDAI -0.01
- INTS -0.00
- Stochastic Oscillator
- ZDAI 7.66
- INTS 19.88
About ZDAI Primega Group Holdings Limited Ordinary Shares
DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.